Y-Intercept (HK)’s 2seventy bio TSVT Stock Holding History

Y-Intercept (HK)’s Portfolio TSVT Stock Details TSVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-67,294	Closed	-$264K	–	1651
2023 Q3	$264K	Buy	+67,294	New	+$441K	0.03%	812

Other funds holding TSVT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

ECM

Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Y-Intercept (HK)'s TSVT Position: Q4 2023 in Review

Y-Intercept (HK) sold out of 2seventy bio (TSVT) in Q4 2023, closing a stake of 67,294 shares — an estimated $264K sold.

Y-Intercept (HK) first reported a position in TSVT in Q3 2023 and held it in 1 quarter. The position peaked at $264K in Q3 2023. 116 funds tracked by Wall St. Rank hold TSVT as of Q4 2023.

Y-Intercept (HK) reported no remaining 2seventy bio position as of Q4 2023 after selling out during the quarter.
Y-Intercept (HK) sold 67,294 2seventy bio shares in Q4 2023, an estimated $264K.
Y-Intercept (HK) first reported a position in 2seventy bio in Q3 2023 and held it in 1 quarter.
Y-Intercept (HK)'s 2seventy bio position peaked at $264K in Q3 2023.
116 funds tracked by Wall St. Rank held 2seventy bio as of Q4 2023.

Based on Y-Intercept (HK)'s 13F filing for Q4 2023, filed 13 Feb 2024.